Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD

Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility of circulating tumor DNA (ctDNA) in the context of CAR-T cell therapy, particularly for relapsed refractory large B-cell lymphoma. This summary highlights the critical aspects of his presentation, emphasizing the revolutionary potential of ctDNA in … Continue reading Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD